---
$id: https://graph.org.ai/products/commodity/51342904
$type: Product
source: UNSPSC
code: "51342904"
title: "Vidarabine"
class: "51342900"
classTitle: "Antiviral purines"
family: "51340000"
familyTitle: "Antiviral drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Vidarabine

**UNSPSC Code**: 51342904
**Class**: [Antiviral purines](Antiviral purines.mdx)
**Family**: [Antiviral drugs](../Antiviral drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a purine antagonist and antiviral agent with the molecular formula C10H13N5O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 3XQD2MEW34, chemically known as 9h-purin-6-amine, 9-beta-d-xylofuranosyl- (9ci) but generally known as vidarabine, which bears US NIH Compound Identifier 191. European Medicines Agency schedules Vidarabine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00047MIG. The term VIDARABINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 24, No. 11 1970, List 10). World Health Organization schedules vidarabine in its Anatomical Therapeutic Chemical (ATC) Classification. VIDARABINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule vidarabine under HS 29349990 and SITC 51579. As of Q4 2014, VIDARABINE remains the US FDA Preferred Term for this commodity. Vidarabine bears US NLM identifiers UMLS ID C0042646 and NCI Concept Code C929. SMILES: C1=NC2=C(C(=N1)N)N=CN2C3C(C(C(O3)CO)O)O.

